Cialis quit working
Posted , 6 users are following.
I have been taking Cialis for 4 months, it helped cut down the nightly bathroom trips, but lately I have had to go 7 times a night. Today I decided to stop taking it. Hope that helps.
0 likes, 9 replies
hank1953 lew82832
Posted
lew82832
Posted
hank1953 lew82832
Posted
cartoonman lew82832
Posted
barrie62598 lew82832
Posted
Internet says CIALIS is approved to treat erectile dysfunction (ED 2.5 mg, 5 mg, 10mg, 20 mg), the signs and symptoms of benign prostatic hyperplasia (BPH 5 mg), and both ED and the signs and symptoms of BPH (5 mg). Taking CIALIS with finasteride when starting BPH treatment has been studied for 26 weeks.
In Australia Drug suppliers are legally bound to report SERIOUS Adverse Drug Reactions (ADR) to our Therapeutic Goods Administration’s (TGA) Database of Adverse Events (DAEN).
There was doubt during trials whether 5ARI component, Dutasteride, and Finasteride reduced the risk of low grade Prostate Cancer (PCa) or increased the risk of SERIOUS PCa. The supplier of Duodart has referred to this in the drug’s Consumer Medicine Information (CMI) but allays the risk as relative to study design. PCa does not appear in the “side effects” on CMI and Urologists therefore do not have to mention this risk to patients they prescribe the drug to.
The Australian supplier of Duodart has reported 6 suspected PCa adverse events relative to the drug. TGA accepts supplier’s reports without Gleason Scores and will not seek this information they say because of privacy issues. How can the severity of the cancer be a privacy issue? This does not make any sense and we are left to assume that as the reports are only required for serious adversities the Gleasons must be high. International healthcare providers have moved away from 5ARIs for BPH for surgery, radiation, laser, electric, heat, water, lifting etc. We are left with this hidden risk, cheap option. Our Commonwealth Ombudsman says only side effects discovered in the trials need to be advised to users. That no matter what adversities surface post-release the risk can remain hidden. No one will tell me what regime is in place to enable the reporting of post-release adversities or how the supplier can isolate their 6 suspected Duodart Prostate Cancers (DPCa) from the thousands of this drugs other user PCas not suspected of being drug related. Trials did prove that a high percentage of 5ARIs user types would progress regardless of their treatment.
I was prescribed Alpha1s 2006 to 2015 (4mg a day). Urologists had known since 1995 that an increased dosage would be required beyond 2 years. As no research had been done by March 2013 I was upgraded to Duodart for 12 months to March 2014 together with the Prazosin. This was contrary to Duodart’s CMI and took my 12 months Alpha1 intake to 8mg a day anyway. No one is looking at the characteristics and other medications of those that are considered DPCas and those that are not. This PBS drug is widely used in Australia to reduce strain on the Budget and is needlessly destroying lifestyles and lives.
I was diagnosed with 3+4 PCa and had the gland removed November 2015. Urologists don’t know the full function of the prostate or the parts lost with it. Hormones are important for whole body outcomes and all sorts of complications have followed. They tell us to assume that even though the gland is gone we still have to assume we have Prostate Cancer cells waiting to declare themselves in other organs and bones.
Before taking any BPH medication research very carefully. Take no healthcare advice without thorough personal investigation. Check internet for pre and post release trial side effects and forums. Check your Health Department’s Adverse Reaction Database then ascertain if the drug company was involved in any reporting.
Had I learned in 2013 that 5ARIs could abnormally alter my testosterone function and prostate cells to possibly change my BPH to PCa I could have just increased my own Alpha intake without the research. They did this anyway without thought. BPH was difficult but ongoing cancer threat, loss of continence, gland function and masculinity is far worse.
Barrie Heslop
j12080 lew82832
Posted
Eliminate the serious first then with the BPH readings and the visual looks at the actual situation you can start to study the options you want to look into. You have a lot of choices. I only know of two PAE and FLA that will cause no sexual side effects and this has been proven out to be the case. It was of most importance to me and I went with FLA. But, the research, studying and analyzation that I put into it took 20 months. It does not have to take that long but I had no one to point me in the right directions. This site is a great source of information. Just do your homework and ask the right questions. Know what it is you want from a procedure before you have one. If it is just sleeping all night long, there are a lot of Urological treatments they are selling. With me it was back to a normal life with no sexual side effects. The answers are out there but you must do your research and not believe a smooth talking doctor who only wants your business. Unfortunately that is the norm in mens BPH issues. There are only a few that really care about you first.
Good Luck
barrie62598 j12080
Posted
I’m at Newcastle NSW Australia some 100 miles north of Sydney, my birthplace. Since 1990 I was monitored for BPH and never had an excessive PSA, ultrasounds were useless and DREs and 6 hit biopsy clear. Urination was at times difficult but liveable. Aplha treatment from 2006 to 2015 and Duodart from March 2013 to March 2014. Gleason 3+4 and Open RP November 2015 at age 72. While they would not increase Alpha dosage above 4mg a day they included Prazosin with the Flomaxtra of Duodart taking it to 8mg a day. I don’t even know if they did this on purpose. Severe incontinence and downhill slide since.
No real alternative options were ever put before me. This forum has substantially highlighted the mountain of options Americans have. Some seem to be highly rated, others seem to have mammoth complications. Urologists are frowned upon while others are placed on high esteem. Since 2015 I have noticed a substantial change from US 5ARI drug treatment to the many physical options. Your FDA was less favourable to 5ARI drug trials than our TGA. We accepted supplier’s more positive look from outcomes that were so flawed the studies should have been redone post MRI or pet scans. In reality the drugs were released without any research. This for a drug that was supposed to unnaturally manipulate testosterone and cell structure without fully knowing the consequences.
Your research must have covered medication options. What caused you to balk at this cheaper easier treatment? Was it the cancer risk?
Barrie Heslop
hank1953 barrie62598
Posted
lew82832
Posted